SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels-Reference-Cited by-同舟云学术

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

Published:2019-01 Issue: Volume:19 Page:1-12
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Suga Takayoshi,Kikuchi Osamu^ORCID,Kobayashi Masaki,Matsui Sho,Yokota-Hashimoto Hiromi,Wada Eri,Kohno Daisuke,Sasaki Tsutomu^ORCID,Takeuchi Kazusane,Kakizaki Satoru^ORCID,Yamada Masanobu,Kitamura Tadahiro

Funder

Mitsubishi Tanabe Pharma Corporation and AstraZeneca K.K

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference51 articles.

1. Islet alpha cells and glucagon--critical regulators of energy homeostasis;Campbell;Nature Reviews Endocrinology,2015

2. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics;Baron;Diabetes,1987

3. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus;Shah;The Journal of Cinical Endocrinology and Metabolism,2000

4. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice;Hancock;Molecular Endocrinology,2010

5. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover;Unger;Journal of Clinical Investigation,2012

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between SGLT2 and systemic blood pressure regulation;Hypertension Research;2024-05-23

2. Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study;Journal of Diabetes;2024-05-23

3. Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon‐like peptide 1;Clinical and Experimental Pharmacology and Physiology;2024-03-25

4. Advances in clinical research on glucagon;Diabetology International;2024-03-23

5. Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 Diabetes;Endocrinology and Metabolism;2024-02-29